Copied
 
 
2023, EUR
25.03.2024
Bruttoresultat

15.257'

Primær drift

2.109'

Årets resultat

849'

Aktiver

10.668'

Kortfristede aktiver

10.633'

Egenkapital

8.243'

Afkastningsgrad

20 %

Soliditetsgrad

77 %

Likviditetsgrad

451 %

Resultat
25.03.2024
Årsrapport
2023
25.03.2024
2022
16.03.2023
2021
31.03.2022
2020
08.06.2021
2019
18.09.2020
2018
03.04.2019
2017
01.06.2018
2016
20.01.2017
2015
14.04.2016
Nettoomsætning
Bruttoresultat15.256.50412.287.1419.406.9104.883.5122.423.114-2.569.142-2.112.610-1.338.209864.833
Resultat af primær drift2.108.5641.018.618809.731481.005000-2.404.127-307.803
Indtægter af kapitalandele (tilknyttede og associerede) 000000000
Finansielle indtægter274.549193.077360.033833.894762.147416.158243.669425.897383.992
Finansieringsomkostninger-288.211-302.800-204.968-1.040.902-714.074-529.405-315.249-383.729-717.478
Andre finansielle omkostninger000000000
Resultat før skat2.094.902908.895964.796273.997417.546-3.864.450-3.144.236-2.361.959-641.289
Resultat849.392818.741764.793213.718323.877-3.659.814-2.741.160-1.842.834-503.972
Forslag til udbytte000000000
Aktiver
25.03.2024
Årsrapport
2023
25.03.2024
2022
16.03.2023
2021
31.03.2022
2020
08.06.2021
2019
18.09.2020
2018
03.04.2019
2017
01.06.2018
2016
20.01.2017
2015
14.04.2016
Kortfristede varebeholdninger000000000
Kortfristede tilgodehavender fra salg og tjenesteydelser 7.664.7146.152.239714.3122.686.4831.347.566802.633987.604614.071308.785
Likvider2.968.2623.428.8345.499.0932.536.8142.729.7933.600.021460.0601.370.9373.347.139
Kortfristede aktiver10.632.9769.581.0736.213.4055.223.2974.077.3594.402.6541.447.6641.985.0083.655.924
Immaterielle aktiver og goodwill000000000
Finansielle anlægsaktiver35.46462.91335.464243.9427.6097.4477.1957.2102.010
Materielle aktiver0254.992178.285000000
Langfristede aktiver35.464317.905213.749243.9427.6097.4477.1957.2102.010
Aktiver10.668.4409.898.9786.427.1545.467.2394.084.9684.410.1011.454.8591.992.2183.657.934
Aktiver
25.03.2024
Passiver
25.03.2024
Årsrapport
2023
25.03.2024
2022
16.03.2023
2021
31.03.2022
2020
08.06.2021
2019
18.09.2020
2018
03.04.2019
2017
01.06.2018
2016
20.01.2017
2015
14.04.2016
Forslag til udbytte000000000
Egenkapital8.243.4077.394.0153.668.8692.904.0762.690.360-12.826.459-9.187.931-6.459.739-4.599.671
Hensatte forpligtelser013.6410000000
Langfristet gæld til banker000000000
Anden langfristet gæld67.4660000000
Leverandører af varer og tjenesteydelser432.118750.220781.5291.039.382499.612147.595294.661400.105187.160
Kortfristede forpligtelser2.357.5671.256.1901.275.1871.813.093618.478261.818385.722585.901367.119
Gældsforpligtelser2.425.0332.491.3222.758.2852.563.1631.394.60817.236.56010.642.7908.451.9578.257.605
Forpligtelser2.425.0332.491.3222.758.2852.563.1631.394.60817.236.56010.642.7908.451.9578.257.605
Passiver10.668.4409.898.9786.427.1545.467.2394.084.9684.410.1011.454.8591.992.2183.657.934
Passiver
25.03.2024
Nøgletal
25.03.2024
Årsrapport
2023
25.03.2024
2022
16.03.2023
2021
31.03.2022
2020
08.06.2021
2019
18.09.2020
2018
03.04.2019
2017
01.06.2018
2016
20.01.2017
2015
14.04.2016
Afkastningsgrad 19,8 %10,3 %12,6 %8,8 %Na.Na.Na.-120,7 %-8,4 %
Dækningsgrad Na.Na.Na.Na.Na.Na.Na.Na.Na.
Resultatgrad Na.Na.Na.Na.Na.Na.Na.Na.Na.
Varelagerets omsætningshastighed Na.Na.Na.Na.Na.Na.Na.Na.Na.
Egenkapitals-forretning 10,3 %11,1 %20,8 %7,4 %12,0 %28,5 %29,8 %28,5 %11,0 %
Payout-ratio Na.Na.Na.Na.Na.Na.Na.Na.Na.
Gældsdæknings-nøgletal 731,6 %336,4 %395,1 %46,2 %Na.Na.Na.-626,5 %-42,9 %
Soliditestgrad 77,3 %74,7 %57,1 %53,1 %65,9 %-290,8 %-631,5 %-324,2 %-125,7 %
Likviditetsgrad 451,0 %762,7 %487,3 %288,1 %659,3 %1.681,6 %375,3 %338,8 %995,8 %
Resultat
25.03.2024
Gæld
25.03.2024
Årsrapport
25.03.2024
Nyeste:01.01.2023- 31.12.2023(offentliggjort: 25.03.2024)
Information om virksomhedens regnskabsklasse:The annual report of Galecto Biotech ApS for 2023 has been prepared in accordance with the provisions of the Danish Financial Statements Act concerning reporting class C (medium). The accounting policies applied are consistent with those of last year. Omission to present a cash flow statement The cash flow statement has not been presented, cf. Danish Financial Statements Act section 86(4). The cash flow statement is included in the consolidated accounts for Galecto Inc. , which can be obtained from the following website: https://ir. galecto. com/sec-filings/sec-filing/10-k/0000950170-24-028610 Presentation currency The financial statements are presented in EUR.
Beretning
25.03.2024
Beskrivelse af usikkerhed ved indregning eller måling:Recognition and measurement uncertainties The recognition and measurement of items in the annual report is not associated with any uncertainty.
Beskrivelse af usædvanlige forhold, der kan have påvirket indregningen eller målingen:Unusual matters The company's financial position at 31 December 2023 and the results of its operations for the financial year ended 31 December 2023 are not affected by any unusual matters.
Statement by Management on the annual report
Identifikation af den godkendte årsrapport:The supervisory board and executive board have today discussed and approved the annual report of Galecto Biotech ApS for the financial year 1 January - 31 December 2023.
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter:Principal activities The company renders research and development services to companies within the Galecto Group and has primarily financed its operations from income from such revenue.